Lantern Pharma Presents Positive Data on the Effectiveness of LP-284 in Hematologic Cancers at the 63rd American Society of Hematology (ASH) Annual Meeting
Go back to Lantern Pharma Presents Positive Data on the Effectiveness of LP-284 in Hematologic Cancers at the 63rd American Society of Hematology (ASH) Annual Meeting| (NASDAQ: LTRN) | Delayed: 3.35 +0.25 (8.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.10 | 52 Week High | $ | |||
| Open | $3.14 | 52 Week Low | $ | |||
| Day High | $3.37 | P/E | N/A | |||
| Day Low | $3.10 | EPS | $ | |||
| Volume | 340,873 | |||||
